海辰药业
(300584)
| 流通市值：31.93亿 | | | 总市值：46.66亿 |
| 流通股本：8211.51万 | | | 总股本：1.20亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 51,240,749.34 | 45,758,717.83 | 38,197,993.87 | 42,603,826.55 |
| 应收票据及应收账款 | 156,598,905.43 | 181,878,032.92 | 187,182,690.43 | 193,040,383.06 |
| 其中：应收票据 | 802,866 | 1,299,626.56 | - | - |
| 应收账款 | 155,796,039.43 | 180,578,406.36 | 187,182,690.43 | 193,040,383.06 |
| 应收款项融资 | 27,500,343.17 | 18,680,564.66 | 3,916,911.74 | 10,851,622.28 |
| 预付款项 | 6,086,981.47 | 6,364,678.69 | 6,092,851.4 | 5,963,501.07 |
| 其他应收款合计 | 455,758.87 | 81,935.26 | 335,356.58 | 664,402.61 |
| 存货 | 86,603,292.19 | 85,670,749.21 | 86,712,359.28 | 89,265,466.93 |
| 其他流动资产 | 11,395,376.74 | 18,719,130.64 | 12,930,636.53 | 11,590,090.16 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 339,881,407.21 | 357,153,809.21 | 335,368,799.83 | 353,979,292.66 |
| 非流动资产: | | | | |
| 长期股权投资 | 8,092,185.37 | - | - | - |
| 其他非流动金融资产 | 131,460,346.88 | 131,460,346.88 | 131,460,346.88 | 131,460,346.88 |
| 投资性房地产 | 13,911,897.05 | 14,174,845.7 | 14,437,794.35 | 14,700,743 |
| 固定资产 | 239,081,615.92 | 211,895,926.4 | 214,241,079.65 | 250,786,268.79 |
| 在建工程 | 560,500,560.35 | 551,834,518.42 | 501,575,562.56 | 440,460,516.8 |
| 使用权资产 | 1,996,164.82 | - | - | - |
| 无形资产 | 131,749,787.48 | 140,802,645.98 | 134,677,953.54 | 140,292,009.77 |
| 开发支出 | 11,316,523.31 | 10,599,681.02 | 26,228,568.06 | 24,595,256.83 |
| 递延所得税资产 | 26,148,233.99 | 25,486,902.26 | 24,307,742.89 | 23,277,345.86 |
| 其他非流动资产 | 15,081,881.2 | 21,138,279.87 | 40,729,279.5 | 45,358,031.8 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,139,339,196.37 | 1,107,393,146.53 | 1,087,658,327.43 | 1,070,930,519.73 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,479,220,603.58 | 1,464,546,955.74 | 1,423,027,127.26 | 1,424,909,812.39 |
| 流动负债: | | | | |
| 短期借款 | 219,573,412.33 | 230,261,895.3 | 212,938,541.53 | 253,969,999.83 |
| 应付票据及应付账款 | 37,655,755.79 | 33,735,868.6 | 54,457,269.03 | 60,228,838.15 |
| 其中：应付票据 | - | - | 28,755,301.16 | 28,866,869.69 |
| 应付账款 | 37,655,755.79 | 33,735,868.6 | 25,701,967.87 | 31,361,968.46 |
| 合同负债 | 1,992,724.22 | 2,350,441.73 | 2,168,024.6 | 2,791,512.52 |
| 应付职工薪酬 | 367,831.19 | 4,346,101.9 | 150,125.37 | 283,804.04 |
| 应交税费 | 15,993,391.48 | 15,165,586.38 | 11,329,613.29 | 14,604,027.12 |
| 其他应付款合计 | 21,502,479.81 | 21,959,413.61 | 23,245,947.81 | 23,489,842.43 |
| 一年内到期的非流动负债 | 22,556,016.41 | 12,178,076.3 | 2,456,666.59 | 12,122,919.94 |
| 其他流动负债 | 16,343,411.72 | 15,353,208.37 | 11,296,848.68 | 13,116,177.59 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 335,985,022.95 | 335,350,592.19 | 318,043,036.9 | 380,607,121.62 |
| 非流动负债: | | | | |
| 长期借款 | 73,000,000 | 72,300,000 | 75,100,000 | 17,800,000 |
| 租赁负债 | 718,913.3 | - | - | - |
| 递延收益 | 6,182,664.04 | 6,242,102.56 | 6,301,541.08 | 6,360,979.6 |
| 递延所得税负债 | 10,215,073.91 | 12,480,575.9 | 13,521,461.93 | 13,454,353.03 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 90,116,651.25 | 91,022,678.46 | 94,923,003.01 | 37,615,332.63 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 426,101,674.2 | 426,373,270.65 | 412,966,039.91 | 418,222,454.25 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 120,000,000 | 120,000,000 | 120,000,000 | 120,000,000 |
| 资本公积 | 211,493,219.8 | 211,493,219.8 | 210,285,601.01 | 210,285,601.01 |
| 专项储备 | 718,337.74 | 735,963.34 | 1,169,530.22 | 1,176,258.71 |
| 盈余公积 | 60,000,000 | 60,000,000 | 60,000,000 | 60,000,000 |
| 未分配利润 | 645,744,020.13 | 630,707,060.37 | 618,605,956.12 | 615,225,498.42 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,037,955,577.67 | 1,022,936,243.51 | 1,010,061,087.35 | 1,006,687,358.14 |
| 少数股东权益 | 15,163,351.71 | 15,237,441.58 | - | - |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,053,118,929.38 | 1,038,173,685.09 | 1,010,061,087.35 | 1,006,687,358.14 |
| 负债和股东权益合计 | 1,479,220,603.58 | 1,464,546,955.74 | 1,423,027,127.26 | 1,424,909,812.39 |
| 公告日期 | 2025-04-21 | 2025-04-21 | 2024-10-26 | 2024-08-23 |
| 审计意见(境内) | | 标准无保留意见 | | |